Indian markets face rising macro risks from global shocks, currency pressure, and energy prices, impacting domestic consumption and corporate earnings. Ajay Srivastava advises aggressive diversification, favoring legacy and promoter-driven companies, while suggesting caution on Indian IT and highlighting selective opportunities in the export-oriented pharma sector.